Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bio-Rad Laboratories (NY: BIO ) 340.78 +3.09 (+0.92%) Streaming Delayed Price Updated: 3:49 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Bio-Rad Laboratories < Previous 1 2 3 Next > S&P 500 Shake-Up: New Entrants Driving Market Momentum September 24, 2024 The quarterly rebalancing of the S&P 500 reflects market capitalization and performance shifts, highlighting growth and challenges in multiple sectors. Via MarketBeat Topics Artificial Intelligence Stocks Exposures Artificial Intelligence US Equities Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference August 22, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer August 20, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading September 13, 2023 Via Investor Brand Network Bio-Rad Reports Second-Quarter 2024 Financial Results August 01, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024 July 17, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics June 05, 2024 Via AB Newswire OncoCyte's Innovative Approach: Potential in Precision Diagnostics June 05, 2024 Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For... Via TheNewswire.com Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group May 30, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference May 23, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Reports First-Quarter 2024 Financial Results May 07, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference May 01, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Announces Life Science Group Management Changes April 26, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 April 18, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Chief Operating Officer Andrew Last to Retire April 10, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer March 20, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day February 22, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results February 15, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024 January 24, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference January 02, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Reports Third-Quarter 2023 Financial Results October 26, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023 October 05, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference August 28, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Reports Second-Quarter 2023 Financial Results August 03, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement July 26, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Announces New Share Repurchase Program July 20, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023 July 10, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Publishes Corporate Sustainability Report for 2022 July 10, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Present Company Overview at Jefferies Healthcare Conference June 01, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference May 08, 2023 From Bio-Rad Laboratories, Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.